<div id="readability-page-1"><p><span>Lam Research (NASDAQ:LRCX - Get Free Report)</span> had its price target increased by Bank of America  from $195.00 to $245.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm presently has a &#34;buy&#34; rating on the semiconductor company's stock. Bank of America's target price suggests a potential upside of 11.16% from the company's current price.</p><ul><li>The S&amp;P 500's Top-Performing Sectors: 3 Lead the Pack in 2025</li></ul><p>Other analysts have also issued reports about the stock. Wells Fargo &amp; Company upped their target price on shares of Lam Research from $135.00 to $145.00 and gave the stock an &#34;equal weight&#34; rating in a research note on Thursday, October 23rd. Berenberg Bank increased their price objective on shares of Lam Research from $122.00 to $165.00 and gave the company a &#34;buy&#34; rating in a research report on Thursday, October 23rd. Citigroup lifted their price objective on shares of Lam Research from $175.00 to $190.00 and gave the stock a &#34;buy&#34; rating in a research report on Tuesday, November 11th. Oppenheimer  set a $200.00 target price on Lam Research and gave the company an &#34;outperform&#34; rating in a report on Thursday, October 23rd. Finally, New Street Research lifted their price target on Lam Research from $105.00 to $140.00 and gave the stock a &#34;neutral&#34; rating in a report on Thursday, October 23rd. Twenty-six research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to MarketBeat.com, Lam Research presently has an average rating of &#34;Moderate Buy&#34; and an average price target of $172.87.</p><p><b>Check Out Our Latest Analysis on Lam Research</b></p><h2>Lam Research Price Performance</h2><ul><li>AI Chips Can’t Exist Without These 2 Underrated Tech Giants</li></ul><p>Lam Research stock opened at $220.40 on Tuesday. The company has a quick ratio of 1.60, a current ratio of 2.21 and a debt-to-equity ratio of 0.37. Lam Research has a 52-week low of $56.32 and a 52-week high of $222.58. The firm has a market cap of $276.83 billion, a PE ratio of 48.55, a price-to-earnings-growth ratio of 2.52 and a beta of 1.77. The company's 50 day moving average is $167.18 and its two-hundred day moving average is $134.20. </p><p>Lam Research (NASDAQ:LRCX - Get Free Report) last posted its quarterly earnings data on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share for the quarter, topping analysts' consensus estimates of $1.22 by $0.04. The business had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.23 billion. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The company's revenue was up 27.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.86 earnings per share. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS.  On average, research analysts expect that  Lam Research will post 3.71 EPS for the current fiscal year. </p><h2>Insider Activity at Lam Research</h2><ul><li>The Chip Boom Is Back: 3 Stocks Positioned for Huge Gains</li></ul><p>In other news, CFO Douglas R. Bettinger sold 40,080 shares of the firm's stock in a transaction that occurred on Friday, November 14th. The shares were sold at an average price of $150.60, for a total transaction of $6,036,048.00. Following the transaction, the chief financial officer directly owned 987,237 shares in the company, valued at approximately $148,677,892.20. This trade represents a 3.90% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Bethany Mayer sold 1,298 shares of Lam Research stock in a transaction on Monday, November 3rd. The shares were sold at an average price of $159.99, for a total transaction of $207,667.02. Following the completion of the transaction, the director directly owned 1,652 shares in the company, valued at $264,303.48. The trade was a 44.00% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 50,418 shares of company stock valued at $7,667,305 in the last three months. 0.31% of the stock is currently owned by company insiders. </p><h2>Institutional Investors Weigh In On Lam Research</h2><p>A number of institutional investors and hedge funds have recently made changes to their positions in LRCX. PMV Capital Advisers LLC purchased a new position in shares of  Lam Research in the 4th quarter valued at approximately $25,000.  IMG Wealth Management Inc. acquired a new stake in shares of  Lam Research during the second quarter worth $26,000.  Stance Capital LLC purchased a new position in  Lam Research in the 3rd quarter valued at $26,000.  Howard Hughes Medical Institute acquired a new position in  Lam Research in the 2nd quarter valued at $27,000.  Finally, Triumph Capital Management acquired a new stake in shares of  Lam Research in the 3rd quarter worth $27,000. 84.61% of the stock is owned by hedge funds and other institutional investors. </p><h2>About Lam Research</h2> (Get Free Report)<p>Lam Research Corporation <span>NASDAQ: LRCX<span></span></span> is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.  </p><p>Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.</p><h2>Read More</h2><ul><li>Five stocks we like better than Lam Research</li><li>Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!</li><li>How a Family Trust May Be Able To Help Preserve Your Wealth</li><li>A U.S. “birthright” claim worth trillions - activated quietly</li><li>Ticker Revealed: Pre-IPO Access to &#34;Next Elon Musk&#34; Company</li><li>This stock gets a 94 out of 100</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TFJDWA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9TFJDWA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Lam Research Right Now?</h2><p>Before you consider Lam Research, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.</p><p>While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

LRCX

<p>Bank of America has raised its price target for Lam Research (NASDAQ:LRCX) from $195.00 to $245.00, maintaining a "buy" rating. This suggests an 11.16% potential upside from the current price. Other analysts have also increased their targets, with an average price target of $172.87. Lam Research reported a quarterly EPS of $1.26, exceeding estimates, and a revenue of $5.32 billion, up 27.7% year-over-year. Insider trading activity includes significant sales by CFO Douglas R. Bettinger and Director Bethany Mayer.</p>

Lam Research (NASDAQ:LRCX) Given New $245.00 Price Target at Bank of America